As of April 2025, Opella is proud to be the first global consumer healthcare company to achieve B Corp™ Certification1, meeting the rigorous social, environmental, and governance standards set by B Lab.
This milestone reflects the culmination of a four-year global transformation, redefining how we operate across all our markets—from North America to Latin America, Asia, the Middle East, and Europe. Every region underwent a comprehensive certification process, demonstrating our commitment to sustainability, community health, and ethical leadership.
Earning B Corp certification is more than a recognition—it’s a validation of our belief that business performance and positive impact go hand in hand. It reflects the work of our 11,000 employees who have made sustainability part of our everyday business and a foundation for future growth. Read more in our official press release.
This certification proves that sustainability is not just a goal—it’s part of how we operate, innovate, and lead.
More details.
- Opella achieved B Corp Certification as a subsidiary of Sanofi, prior to becoming a standalone company. Global consumer healthcare company definition is aligned with Nicholas Hall’s global CHC benchmarks, including market presence, portfolio breadth, and revenue thresholds.
Have a question or simply want to know more?
Any question or adverse reaction related to our products must be addressed via www.sanofi.com.
